Zuwei Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Signal Processing top 5%
- Speech and Audio Processing
Papers in
-
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 2
-
- Renal cell carcinoma treatment 5
- Co-authors
- Ying Chen (1 shared paper)Yongqing Lai (14 shared papers)Xiang Pan (12 shared papers)Liwen Zhao (11 shared papers)Jing Quan (10 shared papers)Hao Liang (2 shared papers)Maja Pantić (3 shared papers)Stavros Petridis (3 shared papers)
- Journals
- Life Sciences (3 papers)Biomedicine & Pharmacotherapy (3 papers)Frontiers in Cardiovascular Medicine (2 papers)IEICE Transactions on Electronics (2 papers)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zuwei Li
47 papers receiving 1k citations
Peers
Comparison fields: 5 of 64
- Cancer Research 310
- Signal Processing 62
- Pulmonary and Respiratory Medicine 219
- Oncology 143
- Endocrine and Autonomic Systems 30
Countries citing papers authored by Zuwei Li
This map shows the geographic impact of Zuwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuwei Li more than expected).
Fields of papers citing papers by Zuwei Li
This network shows the impact of papers produced by Zuwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuwei Li. The network helps show where Zuwei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zuwei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 160 | |
| 2 | 2018 | 111 | |
| 3 | 2020 | 71 | |
| 4 | 2010 | 49 | |
| 5 | 2021 | 45 | |
| 6 | 2021 | 43 | |
| 7 | 2020 | 37 | |
| 8 | 2020 | 37 | |
| 9 | 2018 | 35 | |
| 10 | 2017 | 34 | |
| 11 | 2019 | 34 | |
| 12 | 2020 | 34 | |
| 13 | 2020 | 28 | |
| 14 | 2018 | 25 | |
| 15 | 2023 | 22 | |
| 16 | 2020 | 20 | |
| 17 | 2018 | 19 | |
| 18 | 2018 | 18 | |
| 19 | MiR-378a-5p acts as a tumor suppressor in renal cell carcinoma and is associated with the good prognosis of patients. | 2019 | 18 |
| 20 | 2014 | 16 |
About Zuwei Li
Zuwei Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Signal Processing, Civil and Structural Engineering and Atomic and Molecular Physics, and Optics, having authored 50 papers that have together received 1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Magnetic properties of thin films (6 papers), Renal cell carcinoma treatment (5 papers), Speech and Audio Processing (3 papers), Cancer-related molecular mechanisms research (2 papers), Microwave Engineering and Waveguides (2 papers), Structural Engineering and Materials Analysis (2 papers) and Electrical Contact Performance and Analysis (2 papers). The work is most often cited by research in Cancer Research (310 citations), Signal Processing (62 citations), Pulmonary and Respiratory Medicine (219 citations), Oncology (143 citations) and Endocrine and Autonomic Systems (30 citations). Zuwei Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ying Chen, Yongqing Lai, Xiang Pan, Liwen Zhao, Jing Quan, Hao Liang, Maja Pantić, Stavros Petridis, Zhaohao Wang and Weisheng S. Zhao. Their work appears in journals such as Life Sciences, Biomedicine & Pharmacotherapy, Frontiers in Cardiovascular Medicine, IEICE Transactions on Electronics and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.